Kestra Medical Technologies, LTD Form 4 insider transactions
Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.
NASDAQ
Elizabeth Kwo, a Director of Kestra Medical Technologies, Ltd., sold 4,010 shares of common stock on September 21, 2026 for $24.26 per share.
NASDAQ
Jeffrey Lawrence Schwartz, a Director and 10% owner of Kestra Medical Technologies, Ltd., sold 3,890 shares of common stock on September 8, 2026 for $25.18 per share.
NASDAQ
Elizabeth Kwo, a Director of Kestra Medical Technologies, Ltd., received 7,217 shares of common stock on September 9, 2026.
NASDAQ
Raymond W Cohen, a Director of Kestra Medical Technologies, Ltd., received 7,217 shares of common stock on September 9, 2026.
NASDAQ
Conor Hanley, a Director of Kestra Medical Technologies, Ltd., sold 5,694 shares of common stock on September 8, 2026 for $25.25 per share.
NASDAQ
Kevin C Reilly, a Director of Kestra Medical Technologies, Ltd., sold 2,932 shares of common stock on September 8, 2026 for $25.13 per share.
NASDAQ
Mary Kay Ladone, a Director of Kestra Medical Technologies, Ltd., sold 3,908 shares of common stock on September 8, 2026 for $25.20 per share.
NASDAQ
Brian Daniel Webster, See Remarks and a Director of Kestra Medical Technologies, Ltd., sold 15,000 shares of common stock on August 17, 2026 for $27.48 per share.
NASDAQ
Vaseem Mahboob, Chief Financial Officer of Kestra Medical Technologies, Ltd., sold 26,287 shares of common stock on August 7, 2026.
NASDAQ
Alfred J Ford Jr, Chief Commercial Officer of Kestra Medical Technologies, Ltd., sold 6,275 shares of common stock on August 4, 2026 for $24.09 per share.
NASDAQ
Vaseem Mahboob, Chief Financial Officer of Kestra Medical Technologies, Ltd., sold 6,995 shares of common stock on August 4, 2026.
NASDAQ
Traci S Umberger, See Remarks and a Director of Kestra Medical Technologies, Ltd., sold 3,580 shares of common stock on August 4, 2026 for $24.04 per share.
NASDAQ
Brian Daniel Webster, See Remarks and a Director of Kestra Medical Technologies, Ltd., sold 51,900 shares of common stock on August 4, 2026.
NASDAQ
Timothy P. Moran, Chief Business Officer of Kestra Medical Technologies, Ltd., sold 15,256 shares of common stock on July 30, 2026.
NASDAQ
Alfred J Ford Jr, Chief Commercial Officer of Kestra Medical Technologies, Ltd., sold 27,632 shares of common stock on July 30, 2026.
NASDAQ
Vaseem Mahboob, Chief Financial Officer of Kestra Medical Technologies, Ltd., sold 18,188 shares of common stock on July 30, 2026.
NASDAQ
Traci S Umberger, See Remarks and a Director of Kestra Medical Technologies, Ltd., sold 22,229 shares of common stock on July 30, 2026.
NASDAQ
Brian Daniel Webster, See Remarks and a Director of Kestra Medical Technologies, Ltd., sold 29,822 shares of common stock on July 30, 2026.
NASDAQ
Timothy P. Moran, Chief Business Officer of Kestra Medical Technologies, Ltd., received 39,113 shares of common stock on July 15, 2026.
NASDAQ
Alfred J Ford Jr, Chief Commercial Officer of Kestra Medical Technologies, Ltd., received 58,832 shares of common stock on July 15, 2026.
NASDAQ
Vaseem Mahboob, Chief Financial Officer of Kestra Medical Technologies, Ltd., received 44,118 shares of common stock on July 15, 2026.
NASDAQ
Traci S Umberger, See Remarks and a Director of Kestra Medical Technologies, Ltd., received 58,832 shares of common stock on July 15, 2026.
NASDAQ
Brian Daniel Webster, See Remarks and a Director of Kestra Medical Technologies, Ltd., sold 15,000 shares of common stock on July 15, 2026.
NASDAQ
Kestra Medical Technologies reports insider Timothy P. Moran acquired 227 shares of common stock through the company's Employee Stock Purchase Plan.
NASDAQ
Traci S. Umberger, a Director and Officer at Kestra Medical Technologies, Ltd., acquired 942 shares of common stock through an Employee Stock Purchase Plan.
NASDAQ
Kestra Medical Technologies Director and CEO Brian Daniel Webster reported a sale of 15,000 common shares for $20.8095 per share, executed under a Rule 10b5-1 trading plan.
NASDAQ
Chief Business Officer Timothy P. Moran was granted 22,704 restricted stock units in Kestra Medical Technologies, Ltd.
NASDAQ
Chief Commercial Officer Alfred J. Ford Jr. was granted 25,227 restricted stock units in Kestra Medical Technologies, Ltd.
NASDAQ
Kestra Medical Technologies CFO Vaseem Mahboob was granted 25,227 restricted stock units as part of a three-year vesting plan.
NASDAQ
General Counsel and Chief Administrative Officer Traci S. Umberger was granted 25,227 restricted stock units.